Point72 Asset Management
SURF

Point72 Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Point72 Asset Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-121,250
Closed -$946K – 1227
2021
Q1 		$946K Sell
121,250
-293,750
-71% -$2.94M ﹤0.01% 817
2020
Q4 		$3.83M Sell
415,000
-1,389,020
-77% -$12.1M 0.02% 622
2020
Q3 		$12.4M Buy
+1,804,020
New +$10.9M 0.06% 365

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management's SURF Position: Q2 2021 in Review

Point72 Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2021, closing a stake of 121,250 shares — an estimated $946K sold.

Point72 Asset Management first reported a position in SURF in Q3 2020 and held it in 3 quarters. The position peaked at $12.4M in Q3 2020. 96 funds tracked by Wall St. Rank hold SURF as of Q2 2021.

  • Point72 Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Point72 Asset Management sold 121,250 Surface Oncology, Inc. Common Stock shares in Q2 2021, an estimated $946K.
  • Point72 Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Point72 Asset Management's Surface Oncology, Inc. Common Stock position peaked at $12.4M in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.